Silymarin inhibits melanin synthesis in melanocyte cells

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 5, 2009, Pages 663-667

  Choo, Soo Jin ^a   Ryoo, In Ja ^a   Kim, Young Hee ^a   Xu, Guang Hwa ^a   Kim, Won Gon ^a   Kim, Ki Ho ^b   Moon, Seong Joon ^c   Son, Eui Dong ^c   Bae, Kihwan ^d   Yoo, Ick Dong ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Bioland Ltd   (South Korea)

^c AmorePacific Corporation   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Melanogenesis; Silymarin; Skin lightening; Tyrosinase activity

Indexed keywords

ACTIN; KOJIC ACID; LEVODOPA; MELANIN; MONOPHENOL MONOOXYGENASE; SILYMARIN; ANTIOXIDANT;

ANIMAL CELL; ARTICLE; CELL FREE SYSTEM; CELL IMMORTALIZATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; MELANOCYTE; MELANOGENESIS; MOUSE; NONHUMAN; OXIDATION; PROTEIN EXPRESSION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SKIN PIGMENTATION;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL LINE; CELL SURVIVAL; LEVODOPA; MELANINS; MELANOCYTES; MICE; MONOPHENOL MONOOXYGENASE; SILYMARIN; SKIN PIGMENTATION;

EID: 85047681818     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.05.0016     Document Type: Article

References (34)

1. Ortonne JP, Nordlund JJ. Mechanisms that cause abnormal skin color. In: Norlund JJ et al. eds. The Pigmentary System: Physiology and Pathophysiology. New York: Oxford University Press, 1998: 489-502.
2. Solano F et al. Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Res 2006; 19: 550-571.
3. Lin JY, Fisher DE. Melanocyte biology and skin pigmentation. Nature 2007; 445: 843-850.
4. Hearing VJ, Jimenez M. Analysis of mammalian pigmentation at the molecular level. Pigment Cell Res 1989; 2: 75-85.
5. Kobayashi T et al. Tyrosinase related protein 1 (TRP1) functions as a DHICA oxidase in melanin biosynthesis. EMBO J 1994; 13: 5818-5825.
6. Yokoyama K et al. Molecular cloning and functional analysis of a cDNA coding for human DOPAchrome tautomerase/tyrosinaserelated protein-2. Biochim Biophys Acta 1994; 1217: 317-321
7. Hearing VJ, Tsukamoto K. Enzymatic control of pigmentation in mammals. FASEB J 1991; 5: 2902-2909.
8. Skottova N, Krecman V. Silymarin as a potential hypocholesterolaemic drug. Physiol Res 1998; 47: 1-7.
9. Saller R et al. The use of silymarin in the treatment of liver diseases. Drugs 2001; 61: 2035-2063.
10. Pietrangelo A et al. Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 1995; 109: 1941-1949.
11. Gazak R et al. Oxidised derivatives of silybin and their antiradical and antioxidant activity. Bioorg Med Chem 2004; 12: 5677-5687.
12. Gu M et al. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res 2004; 64: 6349-6356.
13. Singh RP, Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal 2002; 4: 655-663.
14. Singh RP, Agarwal R. Mechanisms and preclinical efficacy of silibinin in preventing skin cancer. Eur J Cancer 2005; 41: 1969-1979.
15. Dooley TP et al. Development of an in vitro primary screen for skin depigmentation and antimelanoma agents. Skin Pharmacol 1994; 7: 188-200.
16. Tsuboi T et al. Enhanced melanogenesis induced by tyrosinase gene-transfer increases boron-uptake and killing effect of boron neutron capture therapy for amelanotic melanoma. Pigment Cell Res 1998; 11: 275-282.
17. Busca R et al. Inhibition of the phosphatidylinositol 3-kinase/ p70(S6)-kinase pathway induces B16 melanoma cell differentiation. J Biol Chem 1996; 271: 31824-31830.
18. Hall AM, Orlow SJ. Degradation of tyrosinase induced by phenylthiourea occurs following Golgi maturation. Pigment Cell Res 2005; 18: 122-129.
19. Parvez S et al. Survey and mechanism of skin depigmenting and lightening agents. Phytother Res 2006; 20(11): 921-923.
20. Flora K et al. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol 1998; 93: 139-143.
21. Zi X et al. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclindependent kinases and associated cyclins. Clin Cancer Res 1998; 4: 1055-1064.
22. Kang JS et al. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1β and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol 2004; 67: 175-181.
23. Gu M et al. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res 2007; 67: 3483-3491.
24. Toklu HZ et al. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. J Surg Res 2008; 145: 214-222.
25. Briganti S et al. Chemical and instrumental approaches to treat hyperpigmentation. Pigment Cell Res 2003; 16: 101-110.
26. Yokota T et al. The inhibitory effect of glabrindin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 1998; 11: 355-361.
27. Lee KK, Choi JD. The effects of areca catechu L extract of antiinflammation and anti-melanogenesis. Int J Cosmet Sci 1999; 21: 275-284.
28. Hasegawa T et al. Bioactive monoterpene glycosides conjugated with gallic acid from the leaves of Eucalyptus globulus. Phytochemistry 2008; 69: 747-753.
29. Park SH et al. Terrein: a new melanogesis inhibitor and its mechamism. Cell Mol Life Sci 2004; 61: 2878-2885.
30. Sato K et al. Down-regulation of tyrosinase expression by acetylsalicylic acid in murine B16 melanoma. Biol Pharm Bull 2008; 31: 33-37.
31. Bennet DC, Lamoreux ML. The color loci of mice: a genetic century. Pigment Cell Res 2003; 16: 333-344.
32. Abdel-Malek ZA et al. In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins. Cancer Res 1987; 47: 3141-3146.
33. Scott G et al. Effects of PGF2α on human melanocytes and regulation of the FP receptor by ultraviolet radiation. Exp Cell Res 2005; 304: 407-416.
34. 2α and its analogues on hair regrowth and follicular melanogenesis in a murine model. Exp Dermatol 2005; 14: 323-328.